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Introduction
Patients with long-term type I diabetes mellitus demonstrate a decrease in muscle strength at the ankle and knee joints (4, 6) . The observed muscle weakness can, in part, be explained by muscle atrophy secondary to diabetic motor neuropathy (5) . However, other cellular mechanisms may be involved in the altered muscle performance associated with diabetes (7) . Investigations using a whole muscle preparation show type I diabetesinduced alterations in muscle performance (33) . Although skeletal muscle atrophy plays a role in the decline in muscle performance, alterations at the single fiber level are implied since the effects of diabetes on skeletal muscle strength are still evident after normalizing for changes in muscle volume and weight (12) .
To further elucidate the mechanisms responsible for muscle weakness associated with the diabetic state, Stephenson et al. investigated the effects of diabetes on single fiber contractile properties, using the permeabilized fiber preparation (43) . Specifically, single fiber specific tension (peak force/cross sectional area) decreased 25% after 4 months of severe diabetes without insulin treatment. These findings suggest that the quality of the contractile proteins declines with uncontrolled diabetes. However, because all type I diagnosed diabetic individuals receive insulin therapy, we studied permeabilized fibers from muscles of rats with and without insulin therapy. We found that despite insulin administration, single fiber diameter and peak force from diabetic rats were reduced compared to fibers from healthy control rats (37) . Interestingly, muscle fibers from the diabetic rats with insulin had significantly larger diameters and peak forces than fibers from the diabetic group without insulin (37) . These results suggest that insulin JAP-01233-2004 4 administration without tight glucose control can only attenuate the progression of muscle atrophy and decline in strength, but it does not totally prevent diabetes-induced muscle atrophy or weakness.
Endurance-exercise training is recommended for patients with diabetes mellitus because it improves glucose control and reduces other risk factors (1) . In normal subjects, endurance-exercise training increased capillarity (24) , decreased capillary basement membrane width (46) and improved vasodilation in skeletal muscle thereby improving blood flow (10) , which is required for the delivery of amino acids to skeletal muscles and stimulation of protein synthesis (44) . Furthermore, endurance exercise increased IGF-1 (14, 18), which has the potential to maintain muscle mass by activating satellite cells (11) and decreasing protein breakdown (28) . In contrast, there is evidence for endurance training-induced fiber atrophy in type II cells (21) . Since endurance training has the potential to either preserve muscle mass or induce atrophy in healthy rats, it is not known which of these effects will predominate in an insulin-treated diabetic state.
In order to mimic the clinical conditions observed in type I diabetic patients, it is necessary to administer insulin and perform the recommended exercise protocol.
Therefore the purpose of this study was to determine the effects of endurance-exercise training on the contractile properties of permeabilized muscle fibers from STZ-induced diabetic rats that received insulin treatment. We hypothesized that single fiber contractile function would be compromised in the diabetic sedentary rats and that endurance exercise would preserve the function.
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Methods
Animal care: The University of Minnesota Institutional Animal Care and Use Committee approved all experimental procedures. Sprague-Dawley rats, 7 week of age and weighing between 200 -250 g. (Charles River, Wilmington, MA) were used in this study (two died of hypoglycemia). They were housed in a light-and temperature-controlled animal facility. Food and water were available ad-libitum. Rats were randomly divided into four groups: non-diabetic sedentary (NS, n=7), non-diabetic exercise (NE, n=7), diabetic sedentary (DS, n=7) or a diabetic exercise (DE, n=7). Diabetes was induced with the intravenous injection of streptozotocin (Sigma), 60 mg/kg of body weight in saline solution. Non-diabetic rats were injected only with saline solution. Diabetes was confirmed 2 days later when blood glucose concentration was at least 250 mg/dl for two consecutive days. Thereafter, blood glucose was measured 3 times per week for the following 12 weeks using the glucose oxidase method (Glucose Analyzer II, Beckman Instruments, Palo Alto, CA). An intermediate lasting (16 -24 hours) subcutaneous neutral protamine Hagedorn (NPH) insulin was administered daily to the diabetic rats at the beginning of the active phase in the evening, according to a sliding scale based on the latest blood glucose values (37) . Insulin was given to mimic the clinical condition of patients, but not to provide tight glucose control. Blood glucose was maintained at approximately 300 mg/dl with this insulin treatment. incline was maintained at 10% throughout the study. This protocol was based on previous research where the speed and grade needed to achieve a specific percentage of VO 2 max and lactate threshold were determined (8, 35) . During the initial 2 weeks, rats started running at a level just below their estimated lactate threshold and at the end they were running at intensities above their initial estimated lactate threshold. To assess training status, blood lactates were determined at the beginning and at the end of the 12 weeks of training on all rats including those that were sedentary. Blood lactate was measured using Single fiber experimental protocol: On the day of the experiment, one of the vials was transported on ice to the experiment room and a bundle was taken out of the vial and placed in a dissecting dish in ice cold relaxing solution, where a single muscle fiber was teased from the bundle. Subsequently, the bundle was placed back into the vial and kept on ice. At the end of the experiment the rest of the unused bundle was placed again in -20°C until the next experimental session.
A single muscle fiber segment measuring between 3 to 4 mm in length was dissected and transferred to an experimental chamber. The chamber was mounted to the stage of an inverted microscope. The chamber included a spring-mounted stainless steel plate insert with 3 wells containing activating or relaxing solutions, this setup allowed the fiber to be transferred from the well, which contained the relaxing solution to a well, which contained the activating solution. The bottom of the well was sealed with a glass coverslip, which allowed the mounted fiber to be transluminated for viewing (3) . by changing the concentration of CaCl 2 . All solutions had enough KCl to achieve an ionic strength of 180 mM and pH was adjusted to 7.00 with KOH.
Determination of fiber diameter: The single fiber was observed through an inverted microscope. The segment length was adjusted to a sarcomere spacing of 2.4 µm in relaxing solution with the use of a calibrated eyepiece. The fiber diameter was determined as the mean of three measurements made along the length of the fiber, and the fiber cross sectional area (CSA) was calculated by assuming a circular cross-section.
Determination of peak active force and peak specific tension: The output of the force transducer was amplified and sent to a microcomputer via a universal input-output board and to an oscilloscope for immediate examination. Data were collected, analyzed and stored by customized software (3). To determine peak active force, the baseline passive force output, in relaxing solution (pCa 8), was monitored. The fiber was then transferred
into activating solution (pCa 3.8), and peak active force of the fiber was determined. The peak specific tension (P o ), defined as the peak active force normalized to fiber crosssectional area, was expressed in kN/m 2 .
Determination of pCa-force measurements: The pCa-force relationship was determined in a series of activating solutions in which the pCa ranged from 3.8 to 6.0. Submaximal force values were expressed relative to peak active force, that is, Pr = peak submaximal force/peak active force at pCa = 3. Fiber type identification and MHC analysis: After physiological measurements were made, the MHC isoform composition of each fiber was determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Each fiber was solubilized in 100 µl of sample buffer containing 1% SDS, 6 mg/ml EDTA, 60 mM tris-HCl (pH 6.8), 2 mg of bromphenol blue/ml, 15% glycerol, and 5% -mercaptoethanol and then stored at -80 °C. In brief, 5 µl of the buffer that contained the solubilized fiber was loaded on gels containing a 3% acrylamide stacking gel and a 5% separating gel. Each muscle fiber was 11 activity and disease. Significance was set at a p < 0.05. All statistical analyses were performed using the statistical software SPSS 11.5.
Results.
Blood glucose, amount of insulin administration, blood lactates and citrate synthase activity.
Blood glucose was not significantly different between diabetic rats, but less insulin was required to maintain the same blood glucose levels in diabetic rats that exercised compared with diabetic rats that were sedentary (Table 1) . After an acute bout of treadmill running at the end of the 12 weeks of endurance exercise training, blood lactates were twice as high in the sedentary groups as in the exercise groups, 5.91 ± 3.48 vs 2.86 ± 1.05 mmol/L respectively. Citrate synthase (CS) activity was not significantly different between diabetics and non-diabetics. Therefore the data were pooled. Citrate synthase activity was significantly greater in the white gastrocnemius muscle from the exercise groups (10.8 umol/g/min) than the sedentary groups (7.8 umol/g/min).
Myosin heavy chain isoform distribution of the single fibers
Fiber type distribution followed expected values for the percentage of MHC fiber types in rat soleus and EDL muscles (7, 13 Figure 1 , Table 2 and Table 3 summarize single fiber contractile characteristics for type II fibers from the EDL muscles and type I fibers from the soleus muscles, respectively.
Diameter. There was an interaction between the disease state of the rat and activity level for type II fiber diameter ( Figure 1A ). The endurance exercise program induced single fiber atrophy in the EDL muscles of non-diabetic rats whereas no atrophy was observed in those muscles from diabetic rats. In addition, diabetes resulted in significant cellular atrophy when rats are sedentary, whereas no atrophy was observed in exercising rats. In the type I fibers, diameter was not influenced by activity or disease (Table 2) .
Force. Consistent with fiber atrophy we observed an 11% lower peak force in type II fibers from diabetic rats ( Figure 1B) . In soleus fibers expressing type I MHC, the force generating capacity was not affected by exercise or diabetes (Table 2) .
Specific Tension. Specific tension of type II fibers was 13% greater in the exercise groups than type II fibers from sedentary groups ( Figure 1C ). The specific tension of the type I fibers was 20% lower in the exercise groups than in the sedentary groups (Table 2) .
Activation threshold and pCa 50
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In type II fibers, activation threshold was unaffected by diabetes or exercise. pCa 50 was significantly greater with endurance training in both diabetic and non-diabetics relative to their sedentary counterparts (Table 3) . No interaction between exercise and disease state was observed for activation threshold or pCa 50 . Activation threshold and pCa 50 of type I fibers from the soleus muscle were not affected by diabetes or exercise (Table 3) .
Discussion.
The interaction of moderately controlled diabetes and endurance exercise training on skeletal muscle contractile function is not known and therefore it is uncertain whether exercise is beneficial or detrimental to these individuals. Thus, the purpose of this study was to characterize the effects of endurance exercise training on the mechanical properties of individual skeletal muscle fibers from insulin-treated STZ-induced diabetic rats. The findings of the present study confirm that the decrease in force observed in single muscle fibers from insulin-treated STZ-induced diabetic rats is due to cellular atrophy and not to changes in the quality of the contractile proteins since specific tension did not change with diabetes (37) . More importantly, the results demonstrate that endurance exercise training does not induce further skeletal muscle fiber atrophy in the rats with diabetes. It is important to note that the effects of a total lack of insulin were not evaluated in this study because the rats were insulin treated. Thus the interpretation of the results must take this into consideration. In addition, blood glucose values were not significantly different between the two diabetic conditions, which argue in favor that the dose of insulin given to groups of diabetic rats had a similar effect in controlling glucose
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15 metabolism and thus on the severity of diabetes on long-term complications. Therefore, the main difference between both groups was the effect of endurance exercise training.
Metabolic adaptations to endurance exercise training.
Endurance-exercised athletes have lower blood lactate values than sedentary individuals after a bout of aerobic exercise at the same intensity (29) . A decrease in lactate production due to an increase in aerobic capacity and an increase in blood lactate clearance are the two most important factors that explain the decrease in blood lactate values in endurance-trained athletes (45) . The lower blood lactate values in the exercisetrained rats in comparison to the sedentary rats in this study and the 38% greater citrate synthase activity in the white gastrocnemius muscle from the endurance exercised rats are indicative of cellular exercise-induced adaptations with this training program.
Type I fibers versus Type II fibers.
Diabetes preferentially affected diameter and peak force of fibers from the EDL muscle (type II fibers), since fibers expressing type I MHC isoform from the soleus did not atrophy. The mechanism that may explain the difference in fiber size adaptations between fibers from the soleus and EDL muscles from diabetic rats is that in the weight-bearing animal, fibers from the soleus muscle are constantly being used (2, 25) . This frequent activation of muscle fibers might prevent fiber atrophy caused by the increased catabolism that is characteristic of diabetes. In addition, the greater blood perfusion reported in the soleus muscle allows for better delivery of nutrients, especially amino acids, which may protect this muscle from the diabetes-induced muscle atrophy (36) .
In the non-diabetic exercise rats, atrophy was observed in fibers expressing type IIB, IIX-IIB MHC isoforms from the EDL muscle, but not in fibers expressing type I MHC isoforms from the soleus muscle. This is probably due to the different mechanical loads experienced by the two muscles during a walking cycle. That is, the soleus muscle performs an isometric contraction while the EDL muscle performs an unloaded contraction during walking (27) . 
Atrophy and Force Generating Capacity
Specific tension was greater in type II fibers from the endurance exercise trained rats relative to the sedentary rats. From the data obtained in this study, we can only speculate on the mechanisms that may explain this greater specific tension. Although an increase in specific tension can result from an increase in the fraction of cross bridges in the JAP-01233-2004 17 strong-binding structural state or an increase in the force generation of each individual cross bridge, these two mechanisms are not likely since a previous study demonstrated that exercise does not modify the structure of myosin (30) .
In general the breakdown of non-contractile proteins can result in fiber atrophy without a significant decrease in force production because the myosin-actin interactions are not perturbed (36) . In the non-diabetic exercise group, we observed a significant decrease in fiber diameter, but peak force was unaffected. This decrease in fiber cross sectional area and maintenance of peak force may be the cause for the increase in specific tension ( Figure 1 ). The decrease in fiber cross-sectional area is part of the adaptation process of muscle fibers to endurance exercise training, which includes an increase in capillarity, increase mitochondrial density, increase in aerobic enzyme activity and lipid oxidation and modification of type II fibers to resemble the characteristics of type I muscle fibers (34) . Thus the decrease in fiber size with endurance training can be viewed as a benefit because it improves the delivery and utilization of oxygen.
Cellular atrophy in the diabetic state (sedentary rats) is related to a combination of diabetic neuropathy, an increase in the catabolic state and the lack of the effects of insulin to promote protein synthesis and inhibit protein breakdown (41, 15, 22, 32, 40) . During a state of absolute or relative insulin deficiency there is an increase in the rate of protein degradation of both structural and contractile proteins due to activation of the ubiquitinproteasome pathway and also a decrease in the rate of protein synthesis (17, 40) . Those alterations in protein turnover promote cellular atrophy. In contrast, single fiber atrophy
is partially reversed by the administration of insulin, most likely due to sustaining protein synthesis (17) . Thus the decrease in fiber size with the diabetic state may be viewed as negative in the sedentary animal.
Prior to the present study, it was unclear whether endurance training would magnify fiber atrophy in the diabetic state. It is possible to speculate that enhanced cellular atrophy would occur when combining endurance training and diabetes because both conditions promote atrophy individually. However, the results of the present study suggest that skeletal muscle fiber atrophy is not enhanced when an insulin-treated diabetic animal performs an aerobic training protocol. The underlying cellular mechanisms most likely involve sustaining protein synthesis rates in the working muscles and minimal changes in degradation rates.
Activation threshold and pCa 50
The pCa-force relationship is used to investigate calcium sensitivity. Two experimental parameters evaluated from this relationship are activation threshold and pCa 50 . In fibers expressing type IIX and IIX,IIB MHC isoforms, diabetes does not change activation threshold, but pCa 50 is significantly higher compared to fibers from non-diabetic rats (37) . An increase in pCa 50 may be due to changes in troponin C, regulatory light-chain phosphorylation, fiber sarcomere length, pH, ionic strength, P i or temperature during the contraction process (31) . Fiber sarcomere length, pH, ionic strength, P i and temperature were all controlled in our experimental protocols. Therefore, changes in either troponin C isoform or in the regulatory light chain phosphorylation status may be implicated for the increase in pCa 50 observed in fibers expressing type IIX and IIX,IIB MHC isoforms from diabetic rats. It is possible that changes in the expression of troponin C from a fast to a slow isoform may have been induced by endurance exercise training (26) . Endurance training in healthy rats results in changes in both activation threshold and pCa 50 (21) .
Specifically, type II skeletal muscle fibers show an increase in sensitivity to calcium following an endurance training program (21, 34) . These endurance-training induced changes in the type II fibers resemble the contractile properties of type I fibers. In the present study, the combination of diabetes and endurance training had an influence on pCa 50 , which is also consistent with endurance training-induced changes in contractile properties of type II fibers (21, 34) . Although it is difficult to conclude if these skeletal muscles fiber changes are beneficial, the findings do indicate that single skeletal muscle fibers maintain their ability to adapt to an endurance training protocol when the animal is in a diabetic state receiving insulin.
Clinical implications
Endurance exercise training is an essential component for the treatment of diabetes mellitus because it helps regulate blood glucose and decreases the risk of long-term cardiovascular complications (38) . However, since decreased muscle strength has been observed in patients with long-term diabetes, endurance exercise training might not be the most appropriate exercise option for this group of individuals. Instead, resistance exercise, which is capable of inducing significant muscle hypertrophy and increase strength, even in moderately diabetic individuals with low serum levels of insulin, might be a more appropriate exercise training option for patients with long-term diabetes and JAP-01233-2004 20 associated muscle weakness (4, 6, 16, 17) . In addition, resistance exercise can also improve HbA 1c , a marker of long-term glucose management, decrease insulin resistance, and lower risk factors for cardiovascular disease (38) . Resistance exercise has been proven to increase muscle strength in elderly patients, which can be explained by an increase in fiber diameter and greater peak force production by individual muscle fibers (19, 23) . This increase in force was associated to improvements in performing activities of daily living (19) . Therefore, a future study should be designed to determine if resistance exercise can increase muscle strength in diabetic patients with low muscle strength.
Summary:
Muscle weakness is caused by atrophy of individual muscle cells in STZ-induced insulin treated diabetic rats and not by changes in the properties of the contractile proteins, since specific tension does not decrease. Endurance exercise does not appear to magnify skeletal muscle atrophy in the diabetic rats. 
